David M Demski
CIK 1555392 · President, CEO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.37M
Companies
4
Total Filings
47
Lifetime Open-Market Net
-$96.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATEC | Director | 431,635 | $9.37 | $4.04M | $224.9K | 9 | 2026-06-12 |
| Paragon 28, Inc. (FNA) Delisted | Director | 0 | $13.09 | $0 | $0 | 2 | 2025-04-21 |
| Axonics, Inc. (AXNX) Delisted | Director | 0 | $70.98 | $0 | $0 | 5 | 2024-11-15 |
| GMED | President, CEO | 121,259 | $85.15 | $10.33M | -$97.20M | 30 | 2022-01-31 |
Recent Filings · Page 2 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-14 | ATEC | Grant (A) | +16,747 | $0 | EDGAR |
| 2023-11-13 | ATEC | Buy (P) | +30,000 | $315.0K | EDGAR |
| 2023-10-19 | ATEC | Grant (A) | +31,694 | $0 | EDGAR |
| 2023-06-28 | Axonics, Inc. (AXNX) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2022-08-22 | Axonics, Inc. (AXNX) Delisted | Grant (A) | +2,100 | $0 | EDGAR |
| 2022-01-31 | GMED | Grant (A) | — | $0 | EDGAR |
| 2021-11-02 | Axonics, Inc. (AXNX) Delisted | Grant (A) | +942 | $0 | EDGAR |
| 2021-04-27 | GMED | Mixed | — | -$9.51M | EDGAR |
| 2021-02-03 | Axonics, Inc. (AXNX) Delisted | Grant (A) | +3,500 | $0 | EDGAR |
| 2021-01-19 | GMED | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.